Beta2-microglobulin amyloidosis in renal failure: Understanding this recently recognized condition
Cleveland Clinic Journal of Medicine. 1999 March;66(3):145-147
March 1, 1999|Cleveland Clinic Journal of Medicine
Author and Disclosure Information
ABSTRACT
Beta2-microglobulin amyloidosis can cause significant suffering in patients with chronic renal failure. Although renal transplantation is currently the only treatment, medical and surgical therapies may decrease pain and disability.
